ABSTRACT Sixty-two consecutive patients with chronic coronary artery disease referred for evaluation of nonsustained ventricular tachycardia (VT) underwent electrophysiologic studies. Sustained VT was induced by one to three ventricular extrastimuli in 28 patients (45%). Therapy was guided by the results of electrophysiologic testing in 44 patients: 19 patients without inducible sustained VT received no antiarrhythmic therapy, and 25 patients with inducible sustained or symptomatic nonsustained VT received therapy guided by the results of electrophysiologic studies. The results of electrophysiologic studies were ignored by physicians for a second group of 18 patients: four had inducible sustained VT but received no antiarrhythmic therapy, and 14 had inducible sustained or nonsustained VT and received antiarrhythmic therapy not guided by results of electrophysiologic testing. After a mean follow-up period of 28 months, 11 patients had died suddenly. Seven of the 11 patients who died suddenly had inducible sustained VT. Three of 44 patients in the group receiving therapy guided by electrophysiologic studies died suddenly versus eight of 18 in the group receiving therapy not guided by electrophysiologic studies (p = .001). Only one of 19 patients without inducible sustained VT who were not treated experienced sudden death. Two of four patients with inducible sustained VT who did not receive antiarrhythmic therapy died suddenly. Multivariate analysis of the relationship of induced arrhythmias, left ventricular ejection fraction, site of myocardial infarction, history of syncope, or type of antiarrhythmic therapy to outcome revealed a greater than twofold increased risk for sudden cardiac death in patients whose therapy was not guided by results of electrophysiologic study. We conclude that patients with coronary artery disease and nonsustained VT who are asymptomatic and are without inducible sustained VT have a relatively low probability of sudden death and do not require antiarrhythmic therapy. Patients with inducible sustained VT are at a significantly increased risk for sudden cardiac death, and in this group therapy that prevents induction of sustained VT is associated with a lower rate of sudden cardiac death than empiric therapy.
has not been defined. Although the detection of nonsustained VT by ambulatory electrocardiographic monitoring after a recent (within 1 month) myocardial infarction is associated with an increased risk for sudden cardiac death, such patients are equally likely to die nonarrhythmic cardiac deaths.1`4 Thus, spontaneous nonsustained VT is not a specific predictor of sudden cardiac death, and it does not necessarily indicate the potential for development of sustained ventricular tachyarrhythmias. Similar observations have been made in ambulatory patients with chronic coronary disease but without recent infarctions. 5 We have previously reported that in approximately 40% of patients with chronic coronary artery disease and nonsustained VT, programmed stimulation will induce sustained CIRCULATION 1178 VT. 6 We and others have suggested that the patients with inducible sustained VT are at increased risk for sudden cardiac death.7 8 The purpose of the present study was to analyze outcome retrospectively in a large group of patients with chronic coronary artery disease who presented with nonsustained VT to determine which patients are most likely to benefit from prophylactic antiarrhythmic therapy, and to evaluate whether antiarrhythmic therapy guided by electrophysiologic testing results in improved survival compared with that of patients receiving antiarrhythmic therapy guided by other means.
Patient population. We studied 62 patients with coronary artery disease who presented with nonsustained VT. No patient had suffered a cardiac arrest remote from an acute myocardial infarction. The mean age of these patients was 60 + 10 years. Coronary artery disease was demonstrated at cardiac catheterization in 53 of the 62 patients. All but three patients had experienced a previous myocardial infarction that occurred a mean of 43 months before electrophysiologic study (range, 2 months to 15 years). Of the 59 patients with prior infarction, two had non-Q wave infarctions, 27 had anterior infarctions, and 30 had inferior infarctions. The left ventricular ejection fraction was 41 ± 15% (mean + SD); 33 patients had ejection fractions of 0.40 or less. Sixteen patients had left ventricular aneurysms demonstrated at cardiac catheterization and/or radionuclide angiography.
Nonsustained VT was detected on "routine" Holter recordings in 33 asymptomatic patients (53%). Nonsustained VT was discovered during evaluation of palpitations in 11 patients (18%) and syncope in 18 patients (29%). Nonsustained VT occurred in each case in the absence of antiarrhythmic drugs. The arrhythmia was not discovered during exercise testing in any case.
Methods
Definitions. Sustained VT was tachycardia lasting longer than 30 sec or in the electrophysiology laboratory requiring termination in less than 30 sec because of hemodynamic decompensation.
Nonsustained VT was that 3 beats to 30 sec in duration at rates of 120 beats/min or more.
Inducible VT was that reproducibly initiated by programmed electrical stimulation. To be considered inducible the tachycardia had to have morphologic characteristics similar to those of the spontaneous nonsustained VT. Because of difficulty obtaining multiple standard electrocardiographic leads of nonsustained VT in most cases, we considered VT to be inducible if the spontaneous and induced VT were both uniform or both polymorphic.
Sudden cardiac death was that witnessed to be instantaneous or unexpected death occurring during sleep.
Protocol for electrophysiologic study. All studies were performed in patients in the nonsedated, postabsorptive state after all antiarrhythmic drugs had been discontinued at least 48 hr. Incremental atrial pacing at a rate of 100 beats/min to the rate that resulted in atrioventricular block was performed, followed by programmed atrial stimulation with single atrial depolarizations at one or more drive cycle lengths at the high right atrium. Right ventricular stimulation was performed at the apex and outflow tract with one to three extrastimuli at two or more drive cycle lengths (most often 600 and 400 msec) and incremental pacing to a minimal cycle length of 250 msec. Bipolar stimuli were delivered with a pulse width of 1 msec at twice diastolic threshold. Single extrastimuli scanned diastole in mean left ventricular ejection fraction in patients with inducible sustained VT (37%) compared with that in those in whom only nonsustained VT was induced (42%) or no VT was induced (49%), but these differences did not reach statistical significance. Electrophysiologically guided surgery (map-guided subendocardial resection) plus coronary artery bypass grafting was performed in two patients (both had noninducible VT after surgery) and coronary artery bypass grafting alone was performed in two patients. Twentytwo patients in the electrophysiologically guided group were discharged off all antiarrhythmic medication. Medications in the nonelectrophysiologically guided group included procainamide in two, quinidine in six, phenytoin in one, tocainide in one, verapamil in one, and amiodarone in two. Coronary artery bypass surgery was performed in one patient and four patients received no antiarrhythmic therapy.
Results of follow-up. No patient was lost to follow-up. After a mean follow-up of 28 months, 18 deaths had occurred. Eleven were sudden and seven occurred nonsuddenly. The interval from infarction to electrophysiologic study (and treatment) in the 11 patients experiencing sudden death ranged from 2 to 72 months (mean 46.7 months). Four of the patients who died suddenly had left ventricular aneurysms. Three of the patients suffering sudden death had a history of syncope. Seven of the sudden deaths occurred in patients with inducible sustained VT. In all cases, the inducible sustained VT had a uniform morphology. In four of seven patients sustained VT was induced by triple extrastimuli. The mean cycle length of induced sustained VT was 268 ± 73 msec in the seven patients who experienced sudden death vs 259 ± 48 msec in the 21 patients without subsequent sudden death (p = NS). Three of the 15 patients in whom only nonsustained VT was induced died suddenly compared with one of the 19 patients without inducible VT (p = NS).
The mean left ventricular ejection fraction in the 11 patients dying suddenly was 37% vs 45% in the patients without sudden death (p = NS). However, sudden death occurred in one of 29 patients with ejection fractions greater than 0.40 vs 10 of 33 patients with ejection fractions of 0.40 (p < .01).
Three of the sudden deaths occurred in the electrophysiologically guided group, while eight occurred in the nonelectrophysiologically guided group (p = .001; figure 3 ). Two patients suffered syncope without documented arrhythmias during follow-up (1 1 and 26 months after study). Neither was receiving antiarrhythmic medication at the time, and one had inducible sustained VT and one had nonsustained VT only. No patient receiving amiodarone died suddenly.
Multivariate analysis of outcome by the Cox proportional-hazards model revealed that the data fit the model with a chi-square value = 17.92 (p = .0005), resulting in a proportional reduction in error due to the model of 37.5%. Three variables achieved moderate statistical significance (p < .10) with respect to relationship to sudden cardiac death. Patients in the nonelectrophysiologically guided group who did not receive therapy had a 2.5-fold increased risk for sudden cardiac death (p = .0087), those in the nonelectrophysiologically guided group who received therapy had a 
Discussion
This study extends previous observations by us and others regarding the role of electrophysiologic studies in the management of patients with nonsustained VT. Earlier smaller studies suggested that the presence of inducible VT in patients with left ventricular dysfunction due to chronic coronary artery disease identified a subset of patients at increased risk for sudden cardiac death.7'8 Our earlier studies suggested that sustained VT was induced only rarely in patients with cardiomyopathy and that programmed stimulation was not likely to be a useful predictor of sudden death in this patient population.1 Based on experience with patients who have spontaneous episodes of sustained VT in association with chronic coronary artery disease, we suspected that reproducible induction of sustained VT indicated a substrate placing these patients at risk for spontaneous episodes of sustained VT. Therefore, we decided that patients who presented with nonsustained VT in whom sustained VT could be reproducibly initiated should receive antiarrhythmic therapy, while those patients without inducible sustained VT should not require specific antiarrhythmic therapy to prevent sudden cardiac death.
Physicians caring for almost one-third of the present group (29%) did not follow recommendations based on the results of electrophysiologic studies. This then formed the basis for a retrospective analysis of outcome based on whether antiarrhythmic therapy was administered according to the results of electrophysiologic studies or other means (e.g., ambulatory electrocardiographic monitoring). Therapy was not randomized in the present study. However .Non EPS,+Rx,EF'40 The optimum protocol for programmed stimulation in this patient population has been debated. Some studies have used only up to two extrastimuli, presumably in hopes of avoiding induction of "nonclinical" arrhythmias.8' 12 However, in this study, over half (four of seven) of the patients with inducible sustained VT who died suddenly required triple extrastimuli for induction. These patients would have been "missed" by less "aggressive" stimulation protocols. Therefore, we believe that it is appropriate to employ three extrastimuli in this patient population, as long as one makes an attempt to distinguish nonspecific (i.e., most polymorphic) from presumably clinically relevant (and therefore treatable) induced tachycardias.
The results of this study support those of earlier studies demonstrating that asymptomatic patients with nonsustained VT in whom sustained VT cannot be induced are at relatively low risk for sudden cardiac death and therefore only a minority are likely to benefit from long-term antiarrhythmic therapy.12 Four sudden deaths occurred in patients without inducible sustained VT. Three of these patients were receiving empiric antiarrhythmic therapy, thus raising the possibility that these drugs exerted a proarrhythmic effect. Seven of the 11 patients experiencing sudden death had inducible sustained VT. Five of these seven patients were in the nonelectrophysiologically guided therapy group. Of note, two of the four patients in the nonelectrophysiologically guided group who had inducible sustained VT and did not receive therapy died suddenly, and three of six patients in this group with inducible sustained VT who were receiving nonelectrophysiologically guided (empiric) therapy died suddenly. In contrast, only two of 18 patients with inducible sustained VT in the electrophysiologically guided group receiving therapy died suddenly. Perhaps more striking are the data from the estimated survival curves. These estimates of survival, based on a model constructed from the data, suggest that electrophysiologically guided therapy is associated with similar survival rates in patients with ejection fractions greater VT, and argued that in patients with nonsustained VT all that programmed stimulation need demonstrate is the ability to induce sustained VT without regard for its morphology.13 However, it seems likely that this would result in a less accurate prediction of subsequent clini-1184 CIRCULATION cal events. We have attempted to circumvent these difficulties in part by considering tachycardias inducible only if both the spontaneous and induced arrhythmia had unifonn morphology or both were polymorphic. Polymorphic tachycardias may appear uniform if only a single electrocardiographic lead is recorded. Thus, we attempted to obtain multiple electrocardiographic leads of the spontaneous tachycardia. However, this was possible in only a minority of the patients. In spite of this limitation, it would appear that programmed stimulation has clinical utility when applied in this manner to patients with nonsustained VT and chronic coronary artery disease.
The patients with inducible sustained VT in the electrophysiologically guided group were more likely to have induction prevented by antiarrhythmic therapy than the patients in the nonelectrophysiologic group. Thus, the differences in survival may be due in part to the ability of electrophysiologic testing to identify a group at high risk of sudden cardiac death, rather than an ability to modify outcome. We believe that the lower risk of sudden death in the patients who responded to antiarrhythmic drugs was due to the fact that they were discharged on a regimen that prevented induction of sustained ventricular tachycardia, rather than an intrinsically lower risk of sudden death. Recent data suggest that patients with spontaneous sustained VT in whom the VT becomes noninducible in response to drugs have significant risk of recurrence if drugs are stopped. 1 The other major limitation of this study is, as described above, the fact that therapy was not administered in a randomized, controlled fashion. However, as previously noted, the analysis has sought to limit potential sources of bias, and our findings do suggest that therapy guided by the results of electrophysiologic testing may result in significantly improved outcome compared with empiric therapy.
